• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Updated Cochrane Review: Effectiveness of Cervical Length Measurement to Prevent Preterm Prevention

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Currently, there are 3 methods to assess cervical length
    • Transvaginal (TVU)
    • Transabdominal (TAU)
    • Transperineal (TPU, also called translabial)
  • Berghella and Saccone (Cochrane Reviews, 2019) follow up on previous review (2013) to analyze the effectiveness of cervical length measurement to prevent preterm birth (PTB)

METHODS:

  • Systematic review and meta-analysis
  • Sources
    • Cochrane Pregnancy and Childbirth’s Trials Register | ClinicalTrials.gov | WHO International Clinical Trials Registry Platform (ICTRP)
    • Contacted experts in the field for additional and ongoing trials
    • 2 new studies included since previous review
  • Inclusion criteria
    • Published and unpublished RCTs
    • Studies that screened women for risk of PTB by cervical length with TVU, TAU, or TPU
      • Knowledge vs no knowledge of cervical length results
      • Ultrasound vs no ultrasound for cervical length
    • Exclusion: Studies focused on effectiveness of interventions based on short cervical length (e.g., progesterone, cerclage or pessary)
  • Participants
    • All pregnant women, between 14 to 32 weeks gestational age
  • Study design
    • Standard Cochrane methodology

RESULTS:

  • 7 RCTs (N = 923) were included, all using TVU
  • Quality of evidence for primary outcome
    • Very low for all population due to limitations in study design, inconsistency between the trials, and imprecision, due to small sample size

Asymptomatic Women with Twin Pregnancies

  • Uncertain whether knowledge of TVU-measured cervical length vs no knowledge reduces PTB <34 weeks (very low quality evidence)
    • Risk ratio (RR) 0.62 (95% CI, 0.30 to 1.25; 1 study, 125 participants)
    • Also inconclusive for PTB <36, <32, or <30 weeks as well as other maternal and perinatal outcomes

Singletons with Symptoms Of PTL

  • Uncertain whether knowledge of TVU-measured cervical length vs no knowledge reduces PTB <37 weeks’ (very low quality evidence)
    • RR 0.59 (95% CI 0.26 to 1.32; 2 studies, 242 participants)
  • Birth occurred approximately four days later in the knowledge groups
    • Mean difference (MD) 0.64 weeks (95% CI, 0.03 to 1.25; 3 trials, 290 women)
  • Also inconclusive for PTB <34 or <28 weeks | Birthweight <2500 g | Perinatal death | Maternal hospitalization | Tocolysis | Steroids for fetal lung maturity

For Singletons with Symptoms Of PPROM

  • Inconclusive for incidence of maternal and neonatal infections between the TVU and no ultrasound groups

For Asymptomatic Singletons

  • Inconclusive for PTB <37 weeks
    • RR 1.27 (95% CI, 0.61 to 2.61; 296 participants)
  • Also inconclusive for gestational age at birth, and other perinatal and maternal outcomes

CONCLUSION:

  • Due to limited data, the authors conclude that that cannot derive

…any conclusions for women with asymptomatic twin or singleton pregnancies, singleton pregnancies with PPROM, or other populations and clinical scenarios

  • Authors propose that future studies should include clear protocols for managing pregnancies based on TVU-measured CLs

Learn More – Primary Sources:

Cervical assessment by ultrasound for preventing preterm delivery

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

Learn More  »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Cervical Cerclage – Professional Recommendations
The Role of Routine Cervical Length Screening For Preterm Birth Prevention
Does Shortened Midtrimester Cervical Length Predict Preterm Birth?
Does Cervical Pessary Benefit Women at risk for Preterm Birth due to Short Cervix?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site